Carfilzomib Impurity 90 CAS CATO-C4X-102290

Purity ≥99.5%In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-102290
Molecular FormulaC40H57N5O7
Molecular Weight719.91 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Carfilzomib Impurity 90 CAS CATO-C4X-102290 chemical structure

Description

CATO manufactures Carfilzomib Impurity 90 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

As a process- or degradation-related impurity, Carfilzomib Impurity 90 (CAS CATO-C4X-102290, C40H57N5O7) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.

Based on its molecular formula C40H57N5O7, Carfilzomib Impurity 90 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 719.91 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

Physical & Chemical Properties

Molecular FormulaC40H57N5O7
Molecular Weight719.91 g/mol
Purity≥99.5%
StorageStore in a cool place (≤25°C), protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)15.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
Nitrogen Atoms5

Related Carfilzomib Standards

Recommended Standards

Why CATO?